Science
Mechanism of Action
No direct mechanism of action related to specific benefits for skin health has been identified in the available research. An in vitro study noted its capacity for acetylcholinesterase inhibition at an IC50 of 0.76 ± 0.04 mg/mL, but this biochemical activity does not directly correlate with established skincare efficacy pathways.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
No data concerning 'dusting' behavior or related thresholds for Pinus Pumila Twig Leaf Oil was found.
The Formula
Formulation
Stability
To prevent dermal sensitization, it is critical to maintain peroxide levels below 10 millimoles peroxide per liter. This typically necessitates the incorporation of antioxidants during the production phase to ensure stability.
Conflicts
- Formulation with other ingredients known to cause irritation may increase the overall risk of skin adverse reactions.
Safety
Safety Profile
PINUS MUGO PUMILIO TWIG LEAF OIL (synonymous with Pinus Pumila Twig Leaf Oil) is approved for cosmetic use under Annex III of the EC Cosmetics Regulation, following assessment by the SCCS. This approval is conditional and may include restrictions on purity, maximum concentration, or specific product categories. The IFRA Critical Effect for this ingredient is identified as dermal sensitization. To ensure safe use, essential oils from the Pinacea family, including Pinus and Abies genera, must be formulated such that peroxide values remain below 10 millimoles peroxide per liter, typically achieved through antioxidant addition during manufacturing.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Given the absence of identified direct skin efficacy, coupled with a moderate risk of dermal sensitization and medium irritancy, this ingredient is questionable for inclusion in precision skincare formulations despite its regulatory approval under specific conditions for fragrance use.
Related
Similar Ingredients
Finding similar ingredients…